Study title:
Krischer-J-P, Steuber-C-P, Vietti-T-J, Culbert-S-J, Ragab-A-H, Morgan-S-K, Berry-D-H, Hvizdala-E, Thomas-P-J, Land-V-J, et al.
Department of Pediatrics, University of Florida, Gainesville.
Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group Study.
Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1989, vol. 17, no. 5, p. 401-8, ISSN: 0098-1532.Krischer-J-P, Steuber-C-P, Vietti-T-J, Culbert-S-J, Ragab-A-H, Morgan-S-K, Berry-D-H, Hvizdala-E, Thomas-P-J, Land-V-J, et al.
Department of Pediatrics, University of Florida, Gainesville.
Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group Study.
Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1989, vol. 17, no. 5, p. 401-8, ISSN: 0...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|